drugset / Trial / NCT01052662
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
Phase 2/3
Completed
87 enrolled
University of Massachusetts, Worcester
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine the effect of memantine and buprenorphine on opioid abusing behavior, to determine the effect of memantine and buprenorphine on early relapse and to evaluate the tolerability of memantine co-administrated with buprenorphine. The study seeks to determine if combined treatment of memantine and buprenorphine may provide shorter-term treatment for opioid dependence.
Timeline
- Start
- 2009-10
- Primary completion
- 2013-06
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 15 mg | Oral |
| Subject | Memantine | Unknown | 30 mg | Oral |